Catalent Pharma Expands in China with Two Deals
publication date: Mar 11, 2013
Catalent Pharma Solutions, a New Jersey company, announced two transactions that will increase its presence in China. First, Catalent will acquire majority share of Zhejiang Jiang Yuan Tang Biotechnology Co., a Haining maker of nutritional softgel products for China and other Asia Pacific markets. And second, Catalent formed a JV with ShangPharma that will provide supplies of drugs for clinical trials. Catalent is involved in drug delivery systems, including soft gels, and it also provides clinical and commercial supplies of drugs world-wide. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.